HRP20020142B1 - Process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyklohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamide and its salts - Google Patents

Process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyklohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamide and its salts

Info

Publication number
HRP20020142B1
HRP20020142B1 HR20020142A HRP20020142A HRP20020142B1 HR P20020142 B1 HRP20020142 B1 HR P20020142B1 HR 20020142 A HR20020142 A HR 20020142A HR P20020142 A HRP20020142 A HR P20020142A HR P20020142 B1 HRP20020142 B1 HR P20020142B1
Authority
HR
Croatia
Prior art keywords
ethoxy
salts
cyklohexan
morfolino
oxospiro
Prior art date
Application number
HR20020142A
Other languages
English (en)
Croatian (hr)
Inventor
H�ja Gergely
Csik�s �va
Er�sn� Tak�csy T�nde
G�nczi Csaba
Hal�sz Judit
Hermecz Istv�n
Majl�th Csilla
Nagy Lajos
S�nt�n� Csutor Andrea
S�rosi P�ter
Simon K�lm�n
Szomor Tiborn�
Szvoboda Gy�rgyn�
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HRP20020142A2 publication Critical patent/HRP20020142A2/hr
Publication of HRP20020142B1 publication Critical patent/HRP20020142B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20020142A 1999-07-15 2000-07-13 Process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyklohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamide and its salts HRP20020142B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902376A HUP9902376A3 (en) 1999-07-15 1999-07-15 Process for producing n-(1,1-dimethyl)-4-[[s'-ethoxi-4-cis-[2-(4-morpholino)-ethoxi]-2'-oxospiro[cyclohexane-1,3'-[3h]indole]-1'(2'h)yl]-sulfonyl]-3-methoxybenzamide and its salts
PCT/HU2000/000078 WO2001005791A2 (fr) 1999-07-15 2000-07-13 NOUVELLE TECHNIQUE DE PREPARATION DE N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-cis-[2-(4-MORFOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'-[H]INDOL]-1'(2'H)-yl]-SULFONYL]-3-METHOXYBENZAMIDE ET SES SELS

Publications (2)

Publication Number Publication Date
HRP20020142A2 HRP20020142A2 (en) 2003-12-31
HRP20020142B1 true HRP20020142B1 (en) 2010-09-30

Family

ID=89998742

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020142A HRP20020142B1 (en) 1999-07-15 2000-07-13 Process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyklohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamide and its salts

Country Status (17)

Country Link
US (1) US6600039B1 (fr)
EP (1) EP1196381B1 (fr)
JP (1) JP2003505389A (fr)
CN (1) CN1174969C (fr)
AT (1) ATE264842T1 (fr)
AU (1) AU6308100A (fr)
BR (1) BR0012425A (fr)
CA (1) CA2378087C (fr)
CZ (1) CZ2002145A3 (fr)
DE (1) DE60010083T2 (fr)
ES (1) ES2216927T3 (fr)
HR (1) HRP20020142B1 (fr)
HU (1) HUP9902376A3 (fr)
MX (1) MXPA01013344A (fr)
PL (1) PL195787B1 (fr)
SK (1) SK285818B6 (fr)
WO (1) WO2001005791A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4823614A (en) * 1986-04-28 1989-04-25 Dahlin Erik B Coriolis-type mass flowmeter
BR0211445A (pt) * 2001-07-31 2004-07-20 Sanofi Synthelabo Processo para a preparação de derivados de 3-espiro' cicloexan-1,3' - '3h! indolin - 2'- ona!

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997015556A1 (fr) * 1995-10-24 1997-05-01 Sanofi Derives 3-spiro-indolin-2-one comme ligands des recepteurs de la vasopressine et/ou de l'ocytocine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997015556A1 (fr) * 1995-10-24 1997-05-01 Sanofi Derives 3-spiro-indolin-2-one comme ligands des recepteurs de la vasopressine et/ou de l'ocytocine

Also Published As

Publication number Publication date
CN1420868A (zh) 2003-05-28
CA2378087C (fr) 2007-12-18
HU9902376D0 (en) 1999-10-28
DE60010083D1 (de) 2004-05-27
HUP9902376A2 (hu) 2001-05-28
HUP9902376A3 (en) 2002-11-28
DE60010083T2 (de) 2005-03-31
CZ2002145A3 (cs) 2002-11-13
CN1174969C (zh) 2004-11-10
JP2003505389A (ja) 2003-02-12
WO2001005791A2 (fr) 2001-01-25
WO2001005791A3 (fr) 2001-07-19
SK285818B6 (sk) 2007-09-06
SK462002A3 (en) 2003-03-04
BR0012425A (pt) 2002-06-11
CA2378087A1 (fr) 2001-01-25
ATE264842T1 (de) 2004-05-15
ES2216927T3 (es) 2004-11-01
PL195787B1 (pl) 2007-10-31
HRP20020142A2 (en) 2003-12-31
AU6308100A (en) 2001-02-05
EP1196381B1 (fr) 2004-04-21
PL352465A1 (en) 2003-08-25
MXPA01013344A (es) 2002-08-20
US6600039B1 (en) 2003-07-29
EP1196381A2 (fr) 2002-04-17

Similar Documents

Publication Publication Date Title
CA2384283A1 (fr) Procede de preparation d'un derive 4-trifluoromethylsulfinylpyrazole
IL145923A0 (en) Tri-aryl acid derivatives as ppar receptor ligands
AP9901442A0 (en) 4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists.
CA2232374A1 (fr) Derives d'acide phenylacetique, procede et intermediaires utilises pour leur production et agents les contenant
EP1176959A4 (fr) Prolines en tant qu'agents antimicrobiens
NO890074L (no) Fremgangsmaate for fremstilling av substituerte pyrrol-, pyrazol- og triazolderivater.
CA2340701A1 (fr) Derives oxindoles en tant qu'agents de liberation de l'hormone de croissance
EP1031573A4 (fr) Nouveaux composes, produits intermediaires, et desherbants de benzoylpyrazole
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
TR199902546T2 (xx) Serotoninerjik maddeler olarak indazol amit bile�ikleri.
NO941977D0 (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
EP0300882A3 (fr) 5-Aminométhylène-2,4-imidazolidinediones et 5-aminométhylène-2-thionoimidazolidin-4-ones
CA2253906A1 (fr) Procede de preparation de derives de pyrimidine
HRP20020142B1 (en) Process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyklohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamide and its salts
BG106784A (en) 3-(4,5-dihydroisoxalole-5-yl)benzoylpyrazole
MXPA03007188A (es) Derivados de 2-heteroaril-3,4-dihidro-2h-pirrol y su uso como agentes pesticidas.
AU4458793A (en) Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
GB9811050D0 (en) Pyrazoles
WO2002012237A3 (fr) Procede de preparation de 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrymidin-7-ones
CA2245484A1 (fr) Nouveaux derives de l'uree
PL345966A1 (en) N-substituted azabicycloheptane derivatives, production and use thereof
AU2001225143A1 (en) Tetramic acid derivatives for use in medicine and food technology
CA2175420A1 (fr) Methode de preparation de derives de substitution facultative en 2 de 5-chloro-imidazole-4-carbaldehydes
AU8553798A (en) Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS, FR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20100813

Year of fee payment: 11

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20110714